Antimetastatic potential of vernolide-A, a sesquiterpenoid from Vernonia cinerea L.

Human and Experimental Toxicology

Volumn 31, Issue 1, 2012, Pages 66-80

  Pratheeshkumar, P ^a   Kuttan, G ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

B16F 10; ERK; metastasis; MMP; VEGF; vernolide A

Indexed keywords

COLLAGEN; GAMMA GLUTAMYLTRANSFERASE; GELATINASE A; GELATINASE B; HEXOSAMINE; HYDROXYPROLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; POLYCARBONATE; SESQUITERPENOID; SIALIC ACID; UNCLASSIFIED DRUG; URONIC ACID; VASCULOTROPIN; VERNOLIDE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENZYME INHIBITION; HISTOPATHOLOGY; LUNG METASTASIS; MALE; MELANOMA CELL; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VERNONIA; VERNONIA CINEREA;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HYDROXYPROLINE; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; N-ACETYLNEURAMINIC ACID; NEOPLASM INVASIVENESS; PHYTOTHERAPY; PLANT EXTRACTS; SESQUITERPENES; URONIC ACIDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VERNONIA;

ANIMALIA; MUS; VERNONIA CINEREA;

EID: 84856048548     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327111414279     Document Type: Article

References (55)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2007 ; 57: 43-66
2. Devi KU. Current status of gynecological cancer care in India. J Gynecol Oncol. 2009 ; 20: 77-80
3. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. clowes memorial award lecture. Cancer Res. 1990 ; 50: 6130-6138 (Pubitemid 20323663)
4. Matsuda H, Morikawa T, Toguchida I, Ninomiya K, Yoshikawa M. Medicinal food stuffs. XXVIII. Inhibitors of nitric oxide production and new sesquiterpenes, zedoarofuran, 4-epicurcumenol, neocurcumenol, gajutsulactones A and B, and zedoarolides A and B, from Zedoariae Rhizoma. Chem Pharm Bull (Tokyo). 2001 ; 49: 1558-1566 (Pubitemid 33126583)
5. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999 ; 274: 21491-21494 (Pubitemid 129519680)
6. Woessner JF, Nagase H Matrix metalloproteinases and TIMPs. Sheterline P, ed. New York: Oxford University Press ; 2002: 126-135.
7. Yang SF, Chen MK, Hsieh YS, Yang JS, Zavras AI, Hsieh YH, et al. Antimetastatic effects of Terminalia catappa L. on oral cancer via a down-regulation of metastasis-associated proteases. Food Chem Toxicol. 2010 ; 48: 1052-1058
8. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005 ; 100: 72-79 (Pubitemid 41073525)
9. Zhang S, Won YK, Ong CN, Shen HM. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr Med Chem Anti-Cancer Agents. 2005 ; 5: 239-249 (Pubitemid 40645593)
10. Kuo YH, Kuo YJ, Yu AS, Wu MD, Ong CW, Kuo LMY, et al. Two novel sesquiterpene lactones, cytotoxic vernolide-A and -B, from Vernonia cinerea. Chem Pharm Bull. 2003 ; 51: 425-426
11. Kumar PP, Kuttan G. Vernonia cinerea L. scavenges free radicals and regulates nitric oxide and proinflammatory cytokines profile in carrageenan induced paw edema model. Immunopharm Immunotoxicol. 2009 ; 31: 94-102
12. Chea A, Hout S, Long C, Marcourt L, Faure R, Azas N, et al. Antimalarial activity of sesquiterpene lactones from Vernonia cinerea. Chem Pharm Bull. 2006 ; 54: 1437-1439 (Pubitemid 44506579)
13. Chen X, Zhan ZJ, Yue JM. Sesquiterpenoids from Vernonia cinerea. Nat Prod Res. 2006 ; 20: 125-129 (Pubitemid 43123624)
14. King JC. Practical clinical enzymology. Van D., ed. Nostrand: London ; 1965: 191-208.
15. Bergmeyer HU, Bernt E Practical clinical biochemistry. Varley H Gowenlock AH Bell M, ed. London: William Heinemann Medical Books ; 1980
16. Toro G, Ackermann PG Boston. MA: Little Brown ; 1975: 154.
17. Murray RL Clinical chemistry: theory, analysis and co-relation. Kaplan LA Pesce AJ, ed. Toranto: Mosby C.V. ; 1984: 1230-1268.
18. Liotta LA. B16F-10 cells readily causes pulmonary metastasis after injection through tail vein. Cancer Res. 1986 ; 46: 1-4
19. Liotta LA. Tumor invasion and metastasis: role of extracellular matrix. Cancer Res. 1986 ; 46: 1-7
20. Bergman I, Loxley R. The determination of hydroxyproline in urine hydrolysate. Clin Chim Acta. 1940 ; 27: 347-349
21. Elson LA, Morgan WT. A colorimetric method for determination of glucosamine. J Biochem. 1933 ; 27: 1824-1828
22. Bitter T, Muir HM. A modified uronic acid carbazole reaction. Anal Biochem. 1962 ; 4: 330-334
23. Skoza L, Mohos S. Stable thiobarbituric acidchromophore with dimethyl sulphoxide. Application to sialic acid assay in analytical de acylation. J Biochem. 1976 ; 159: 457-462
24. Szasz G. Reaction rate method for gamma glutamyl transpeptidase in serum. Clin Chem. 1976 ; 22: 2031-2055
25. Chomczynski P, Sacchi N. Single-step method for RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 ; 162: 156-159 (Pubitemid 17064313)
26. Cole SPC. Rapid chemosensitivity testing of human lung tumour cells using MTT assay. Cancer Chemother Pharmocol. 1986 ; 17: 259-263 (Pubitemid 16070936)
27. Campling BG, Pyn J, Baker HM, et al. Chemosensitivity testing of small cell lung cancer using the MTT assay. Br J Cancer. 1991 ; 63: 75-83
28. Albini A, Iwamoto HK, Kleinman GR, et al. A rapid in vitro assay quantitating the invasive potential of tumor cells. Cancer Res. 1987 ; 47: 3239-3245 (Pubitemid 17082655)
29. Billings PC, Habres TM, Liao DC, et al. Human fibroblast contain aproteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res. 1991 ; 51: 5539-5543
30. Hill LL, Perussia B, McLeu PA, et al. Effect of natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency. Cancer Res. 1994 ; 54: 763-770 (Pubitemid 24068334)
31. Ogasawara M, Matsubara T, Suzuki H. Screening of natural compounds for inhibitory activity on colon cancer cell migration. Biol Pharm Bull. 2001 ; 24: 720-723 (Pubitemid 32586670)
32. Menon LG, Kuttan R, Kuttan G. Inhibition of lung metastasis in mice induced by B16F-10 melanoma cells by polyphenolic compounds. Cancer lett. 1995 ; 95: 221-225
33. Menon LG, Kuttan R, Kuttan G. Anti-metastatic activity of curcumin and catechin. Cancer Lett. 1999 ; 141: 159-165 (Pubitemid 29261735)
34. Raphael TJ, Kuttan G. Effect of naturally occurring monoterpenes carvone, limonene and perillic acid in the inhibition of experimental lung metastasis induced by B16F-10 melanoma cells. J Exp Clin Cancer Res. 2003 ; 22: 419-424 (Pubitemid 37205399)
35. Pradeep CR, Kuttan G. Effect of beta-carotene on the inhibition of lung metastasis in mice. Phytomedicine. 2003 ; 10: 159-164 (Pubitemid 36433211)
36. Leyon PV, Kuttan G. Effect of Withania somnifera on B16F-10 melanoma induced metastasis in mice. Phytother Res. 2004 ; 18: 118-122 (Pubitemid 38380604)
37. Leyon PV, Lini CC, Kuttan G. Inhibitory effect of Boerhaavia diffusa on experimental metastasis by B16F10 melanoma in C57BL/6 mice. Life Sci. 2005 ; 76: 1339-1349
38. Sunila ES, Kuttan G. A preliminary study on antimetastatic activity of Thuja occidentalis L. in mice model. Immunopharmacol Immunotoxicol. 2006 ; 28: 269-280 (Pubitemid 44180244)
39. Thejass P, Kuttan G. Antimetastatic activity of sulforaphane. Life Sci. 2006 ; 78: 3043-3050
40. Manu KA, Kuttan G. Anti-metastatic potential of punarnavine, an alkaloid from Boerhaavia diffusa Linn. Immunobiology. 2009 ; 214: 245-255
41. Voet JG Biochemistry. New York: John Wiley ; 1995: 256.
42. Dennis JW, Laxerte S, Waghorne C, Breitman MI. Kerbel RS. 1-6 branching of ASN-linked oligosaccharides is directly associated with metastasis. Science. 1987 ; 236: 582-585 (Pubitemid 17069927)
43. Fernandes B, Sugman U. Auger M, and Dennis JW. 1-6 branched oligosaccharide as a marker of tumor progression in human breast and coloric neoplasis. Cancer Res. 1991 ; 51: 718-723
44. Matous B, Ciganek EF, Budesinska A, Duchon J. Biochemical markers of malignant melanoma. Neoplasia. 1987 ; 34: 7-84
45. Westermarck J, Kahari VM. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999 ; 13: 781-792 (Pubitemid 29220691)
46. Yoon SO, Park SJ, Yun CH, Chung AS. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol. 2003 ; 36: 128-137
47. Salo T, Turpeenniemi-Hujanen T, Tryggvason K. Tumor promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinase by human fibroblasts. J Biol Chem. 1985 ; 260: 8526-8531 (Pubitemid 15011825)
48. Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol. 1996 ; 149: 273-282 (Pubitemid 26230998)
49. Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N, Ross JS. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res. 2001 ; 7: 3113-3119 (Pubitemid 32963832)
50. Yoshizaki T, Maruyama Y, Sato H, Furukawa M. Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer. 2001 ; 95: 44-50
51. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. The matrix metalloproteinases: biological activity and clinical implications. J Clin Oncol. 2000 ; 18: 1135-1149 (Pubitemid 30123793)
52. Munaut C, Noel A, Hougrand O, Foidart JM, Boniver J, Deprez M. Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int J Cancer. 2003 ; 106: 848-855 (Pubitemid 37071662)
53. Liotta LA, Stetler-Stevenson WG, Steeg PS. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest. 1991 ; 9: 543-551
54. Cavallaro U, Christofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta. 2001 ; 1551: 39-45 (Pubitemid 34066627)
55. Kohno M, Pouyssegur J. Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Progress Cell Cycle Res. 2003 ; 5: 219-224